Human allogenic γδ T cells kill patient-derived glioblastoma cells expressing high levels of DNAM-1 ligands
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - October 31, 2022 Category: Cancer & Oncology Authors: Haeyoun Choi Yunkyung Lee Soon A Park Ji Hyeon Lee Junseong Park Jang Hyun Park Heung Kyu Lee Tai-Gyu Kim Sin-Soo Jeun Stephen Ahn Source Type: research
Fully murine CD105-targeted CAR-T cells provide an immunocompetent model for CAR-T cell biology
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - October 18, 2022 Category: Cancer & Oncology Authors: Konstantinos Lontos Yiyang Wang Mason Colbert Alok Kumar Supriya Joshi Mary Philbin Yupeng Wang Andrew Frisch Jason Lohmueller Dayana B. Rivadeneira Greg M. Delgoffe Source Type: research
Neoadjuvant PD-1 blockade plus chemotherapy induces a high pathological complete response rate and anti-tumor immune subsets in clinical stage III gastric cancer
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - October 15, 2022 Category: Cancer & Oncology Authors: Xiaohuan Tang Mengyuan Li Xiaolong Wu Ting Guo Li Zhang Lei Tang Fangzhou Jia Ying Hu Yan Zhang Xiaofang Xing Fei Shan Xiangyu Gao Ziyu Li Source Type: research
Targeting depletion of myeloid-derived suppressor cells potentiates PD-L1 blockade efficacy in gastric and colon cancers
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - October 14, 2022 Category: Cancer & Oncology Authors: Yao Tang Cong Zhou Qingli Li Xiaojiao Cheng Tinglei Huang Fuli Li Lina He Baiweng Zhang Shuiping Tu Source Type: research
RHOA G17V induces T follicular helper cell specification and involves angioimmunoblastic T-cell lymphoma via upregulating the expression of PON2 through an NF- κB-dependent mechanism
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - October 11, 2022 Category: Cancer & Oncology Authors: Fenglian Que Lihong Zhang Taoli Wang Meifang Xu Wangen Li Shengbing Zang Source Type: research
AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - October 11, 2022 Category: Cancer & Oncology Authors: M.I. Strecker K. Wlotzka F. Strassheimer B. Roller G. Ludmirski S. K önig J. R öder C. Opitz T. Alekseeva J. Reul L. Sevenich T. Tonn W.S. Wels J.P. Steinbach C.J. Buchholz M.C. Burger Source Type: research
Systemic T-cell and humoral responses against cancer testis antigens in hepatocellular carcinoma patients
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - October 6, 2022 Category: Cancer & Oncology Authors: Lisanne Noordam Monique T.A. de Beijer Shanta Mancham Isabel Vogler Patrick P.C. Boor Valeska de Ruiter Robbie Luijten Jan N.M. IJzermans Ugur Sahin Marco J. Bruno Dave Sprengers Sonja I. Buschow Jaap Kwekkeboom Source Type: research
Nanoparticles releasing immunogenic cell death inducers upon near-infrared light exposure
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - October 5, 2022 Category: Cancer & Oncology Authors: Oliver Kepp Giulia Cerrato Allan Sauvat Guido Kroemer Source Type: research
A newly discovered PD-L1 B-cell epitope peptide vaccine (PDL1-Vaxx) exhibits potent immune responses and effective anti-tumor immunity in multiple syngeneic mice models and (synergizes) in combination with a dual HER-2 B-cell vaccine (B-Vaxx)
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - October 5, 2022 Category: Cancer & Oncology Authors: Linlin Guo Jay Overholser Heather Darby Nicholas J. Ede Pravin T.P Kaumaya Source Type: research
Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - October 3, 2022 Category: Cancer & Oncology Authors: Rebecca Adams Gabriel Osborn Bipashna Mukhia Roman Laddach Zena Willsmore Alicia Chenoweth Jenny L C Geh Alastair D MacKenzie Ross Ciaran Healy Linda Barber Sophia Tsoka Victoria Sanz-Moreno Katie E Lacy Sophia N Karagiannis Source Type: research
Immune targeting of three independent suppressive pathways (TIGIT, PD-L1, TGF β) provides significant antitumor efficacy in immune checkpoint resistant models
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - October 2, 2022 Category: Cancer & Oncology Authors: S. Elizabeth Franks Kellsye P. Fabian Ginette Santiago-S ánchez Benjamin Wolfson James W. Hodge Source Type: research
Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - October 1, 2022 Category: Cancer & Oncology Authors: Shuo Liu Zhen Qin Yaqing Mao Wenbo Zhang Yujia Wang Lingfei Jia Xin Peng Source Type: research
PDIA3 as a potential bridge between immunogenic cell death and autoreactivity
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - October 1, 2022 Category: Cancer & Oncology Authors: Jonathan G. Pol C éleste Plantureux Mar ía Pérez-Lanzón Guido Kroemer Source Type: research
Small extracellular vesicles: multi-faceted tools for leukemia immune evasion in vivo
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - September 27, 2022 Category: Cancer & Oncology Authors: Ernesto Gargiulo Elodie Viry Etienne Moussay Jerome Paggetti Source Type: research
Immunotherapy approaches for the treatment of diffuse midline gliomas
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - September 27, 2022 Category: Cancer & Oncology Authors: Joshua D. Bernstock Samantha E. Hoffman Ari D. Kappel Pablo A. Valdes Walid Ibn Essayed Neil V. Klinger Kyung-Don Kang Stacie K. Totsch Hannah E. Olsen Charles W. Schlappi Katharina Filipski Florian A. Gessler Lissa Baird Mariella G. Filbin Rintaro Hashiz Source Type: research
